Print

Shareholders Approve Merger Of AGT Biosciences (AGTGF) And ChemGenex Therapeutics, Inc. To Form ChemGenex Pharmaceuticals Limited 
10/19/2005 5:08:47 PM

AGT Biosciences Limited (ASX:AGT) and ChemGenex Therapeutics, Inc. are pleased to announce that they have completed their merger transaction. The merger creates a genomics-driven global biotechnology company with two products in Phase II clinical development, and discovery and development capabilities in oncology, diabetes, obesity and depression.
//-->